Neuroprotective effect of D-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells

被引:97
作者
Takata, MK
Yamaguchi, F
Nakanose, Y
Watanabe, Y
Hatano, N
Tsukamoto, I
Nagata, M
Izumori, K
Tokuda, M
机构
[1] Kagawa Univ, Fac Med, Dept Cell Physiol, Kagawa 7610793, Japan
[2] Kagawa Univ, Rare Sugar Res Ctr, Kagawa 7610795, Japan
[3] Teikoku Seiyaku Co Ltd, Kagawa 7692695, Japan
[4] Kagawa Ind Support Fdn, Kagawa 7610301, Japan
[5] Kagawa Univ, Fac Med, Dept Pharm Bioinformat, Kagawa 7610793, Japan
关键词
rare sugars; D-psicose; 6-hydroxydopamine (6-OHDA); Parkinson's disease (PD); apoptosis; antioxidant; PC12; cells;
D O I
10.1263/jbb.100.511
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We evaluated the neuroprotective effects of D-psicose, one of the rare sugars, on 6-hydroxydopamine (6-OHDA)-induced apoptosis in catecholaminergic PC12 cells, the ill vitro model of Parkinson's disease (PD). Apoptotic characteristics of PC12 cells were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and terminal deoxynucleotidyl transferase mediated dUTP nick end-labeling (TUNEL) assay. The results showed that D-psicose at a concentration of 50 mM, exerted significant protective effects against the 6-OHDA (200 mu M)-induced PC12 cell apoptosis, while other sugars had little or no protective effects. We have observed a significant increase in the level of intracellular glutathione after 24 h in 6-OHDA (200 mu M) treated cells, while a decrease in the level was observed at 3 h and 6 h. Also, a synergistic exposure to D-psicose and 6-OHDA for 24 h showed a significant increase in intracellular glutathione level. Therefore, these results suggest that D-psicose may play a potential role as a neuroprotective agent in the treatment of neurodegenerative diseases by inducing an up-regulation of intracellular glutathione.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 27 条
[1]   Glutathione, iron and Parkinson's disease [J].
Bharath, S ;
Hsu, M ;
Kaur, D ;
Rajagopalan, S ;
Andersen, JK .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :1037-1048
[2]   D-allose production from D-psicose using immobilized L-rhamnose isomerase [J].
Bhuiyan, SH ;
Itami, Y ;
Rokui, Y ;
Katayama, T ;
Izumori, K .
JOURNAL OF FERMENTATION AND BIOENGINEERING, 1998, 85 (05) :539-541
[3]   Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J].
Blum, D ;
Torch, S ;
Lambeng, N ;
Nissou, MF ;
Benabid, AL ;
Sadoul, R ;
Verna, JM .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) :135-172
[4]   Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis [J].
Di Matteo, Vincenzo ;
Esposito, Ennio .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (02) :95-107
[5]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[6]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[7]  
Glinka Y, 1997, J NEURAL TRANSM-SUPP, P55
[9]  
Han SK, 1996, J NEUROCHEM, V66, P501
[10]  
HART J, 1994, MICROCONTAMINATION, V12, P63